Using collective data made available by IBD Plexus, researchers’ findings advance the possibility of microbiome-based personalized medicine for IBD treatment.
The Crohn's & Colitis Foundation advocates for reform in the Pharmacy Benefit Manager (PBM) industry due to the negative impact it has on patients' access to medicine.